PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
20978160-10	2010	Angiotensin II induced VEGF production in CDDP-treated cells; however, the AT1R antagonist significantly inhibited the increase in VEGF.	cddp	42-46	vascular endothelial growth factor A	Homo sapiens	23-27	
20978160-11	2010	The in vivo study results also showed that CDDP treatment upregulated AT1R expression, resulting in increased VEGF.	cddp	43-47	vascular endothelial growth factor A	Homo sapiens	110-114	
20978160-12	2010	Clinical specimens from patients who underwent cystectomy after neoadjuvant CDDP-based chemotherapy showed significantly higher AT1R and VEGF expression than corresponding transurethral resection specimens.	cddp	76-80	vascular endothelial growth factor A	Homo sapiens	137-141	
20978160-13	2010	Our findings indicate that CDDP upregulates AT1R expression though ROS generation and enhances VEGF production.	cddp	27-31	vascular endothelial growth factor A	Homo sapiens	95-99	
15770730-5	2005	IFN-alpha is also able to prevent the increase in proliferation rate and VEGF secretion of CDDP resistant cells.	cddp	91-95	vascular endothelial growth factor A	Homo sapiens	73-77